** U.S.-listed shares of cannabis company Cronos CRON.O up
3.2% at $1.95 premarket
** Co's quarterly revenue jumps 22% to $24.8 million from a
year ago, vs analyst's estimates of $19.8 million per LSEG data
** Higher sales in Canada drove revenue growth, says co
** Net loss narrows to $1.5 mln from $33 mln in the previous
year
** Co says it continues to monitor the ongoing conflict and
the potential impact on co's personnel and business in Israel
** Up to last close, stock has fallen ~25.6% YTD
(Reporting by Kabir Dweit)
((Kabir.Dweit@thomsonreuters.com))